文献速递自身炎症与 IgG4 相关病其他结缔组织病

NLRP1突变相关的新自身炎症与自身免疫综合征:NAIAD

A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis).
PubMed 文献 · Ann Rheum Dis · 2016-12-13

该研究通过纯合子定位和外显子测序,在两个无亲缘关系的家庭的三例患者中发现NLRP1突变与一种新疾病相关,表现为弥漫性皮肤角化不良、自身炎症、自身免疫、关节炎及高过渡性B细胞水平。患者系统性caspase-1和白细胞介素18水平升高,提示NLRP1炎症小体参与。作者提出将其命名为NAIAD(NLRP1相关自身炎症伴关节炎和角化不良)。

要点

  • NAIAD由NLRP1突变引起,表现为关节炎、皮肤角化不良、自身炎症和自身免疫。
  • 患者caspase-1和白细胞介素18水平升高,提示NLRP1炎症小体活化。
  • NLRP1突变可为纯合错义突变或新发杂合突变。

核心结论

  • 人类NLRP1突变导致一种新的自身炎症性疾病,命名为NAIAD。
  • NAIAD兼具自身炎症和自身免疫特征。

研究设计与样本

  • 为寻找系统性幼年特发性关节炎的新基因,采用纯合子定位和外显子测序。
  • 对患者血液样本进行免疫学检测。
  • 研究纳入来自两个无亲缘关系家庭的三例患者。

主要发现

  • 三例患者表现为弥漫性皮肤角化不良、自身炎症、自身免疫、关节炎和高过渡性B细胞水平。
  • 两例表亲患者(阿尔及利亚近亲婚配父母所生)携带NLRP1纯合错义突变c.2176C>T(p.Arg726Trp)。
  • 一例荷兰籍女孩携带新发杂合突变c.3641C>G(p.Pro1214Arg)。
  • 三例患者系统性caspase-1和白细胞介素18水平升高。

临床怎么用

  • 对表现为关节炎、皮肤角化不良、自身炎症和自身免疫重叠的患者,应考虑NLRP1突变相关NAIAD。
  • 检测caspase-1和白细胞介素18水平可能提示NLRP1炎症小体活化。

局限性

  • 仅报告三例患者,样本量小。
  • 未提供治疗或随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Inflammasomes are multiprotein complexes that sense pathogens and trigger biological mechanisms to control infection. Nucleotide-binding oligomerisation domain-like receptor (NLR) containing a PYRIN domain 1 (NLRP1), NLRP3 and NLRC4 plays a key role in this innate immune system by directly assembling in inflammasomes and regulating inflammation. Mutations in NLRP3 and NLRC4 are linked to hereditary autoinflammatory diseases, whereas polymorphisms in NLRP1 are associated with autoimmune disorders such as vitiligo and rheumatoid arthritis. Whether human NLRP1 mutation is associated with autoinflammation remains to be determined. METHODS: To search for novel genes involved in systemic juvenile idiopathic arthritis, we performed homozygosity mapping and exome sequencing to identify causative genes. Immunoassays were performed with blood samples from patients. RESULTS: We identified a novel disease in three patients from two unrelated families presenting diffuse skin dyskeratosis, autoinflammation, autoimmunity, arthritis and high transitional B-cell level. Molecular screening revealed a non-synonymous homozygous mutation in NLRP1 (c.2176C>T; p.Arg726Trp) in two cousins born of related parents originating from Algeria and a de novo heterozygous mutation (c.3641C>G, p.Pro1214Arg) in a girl of Dutch origin. The three patients showed elevated systemic levels of caspase-1 and interleukin 18, which suggested involvement of NLRP1 inflammasome. CONCLUSIONS: We demonstrate the responsibility of human NLRP1 in a novel autoinflammatory disorder that we propose to call NAIAD for NLRP1-associated autoinflammation with arthritis and dyskeratosis. This disease could be a novel autoimmuno-inflammatory disease combining autoinflammatory and autoimmune features. Our data, combined with that in the literature, highlight the pleomorphic role of NLRP1 in inflammation and immunity. TRIAL REGISTRATION NUMBER: NCT02067962; Results.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Grandemange S, Sanchez E, Louis-Plence P, et al. A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis). Ann Rheum Dis. 2016. PMID: 27965258. doi:10.1136/annrheumdis-2016-210021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。